Food and Drug Administration (FDA)

Kyle Diamantas

Biotech

HHS unveils plan to speed up ph. 1 trials by 6 to 12 months

The reforms are meant to hasten early clinical development and encourage companies to conduct trials in the U.S. rather than speedier locales.

Darren Incorvaia Jun 22, 2026 12:10pm

artificial intelligence concept with business analytics

Fierce Healthcare

HHS ramps up AI use cases, with most in pre-deployment: BPC

Jun 11, 2026 2:00pm

FDA

At CNPV hearing, industry support meets ‘concern’ from experts

Jun 5, 2026 5:00am

FDA stop sign

Fulcrum scraps SCD plan as FDA takes hard line on safety risks

Jun 2, 2026 8:46am

Martin Makary FDA Senate HELP confirmation

Makary FDA reforms ‘continue to move forward’ despite turmoil

May 26, 2026 10:27am

revolving door office

CBER chief Prasad steps aside, deputy takes the reins

May 1, 2026 9:58am